Mucoadhesive Drug Delivery Systems
暂无分享,去创建一个
Javed Ali | Alka Ahuja | J. Ali | A. Ahuja | R. Khar | Roop K. Khar
[1] M. Rathbone. Human buccal absorption. I. A method for estimating the transfer kinetics of drugs across the human buccal membrane , 1991 .
[2] Hans Bisgaard,et al. Bioadhesive microspheres as a potential nasal drug delivery system , 1987 .
[3] N. M. Sanghavi,et al. Novel drug delivery system for captopril , 1992 .
[4] T. Nagai,et al. New mucosal dosage form of insulin. , 1981, Chemical & pharmaceutical bulletin.
[5] D. Attwood,et al. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. , 1994, Biological & pharmaceutical bulletin.
[6] J. Robinson,et al. Preliminary studies of oral mucosal delivery of peptide drugs , 1987 .
[7] J. Tukker,et al. Mucoadhesion of both film-forming and non-film-forming polymeric materials as evaluated with the Wilhelmy plate method , 1992 .
[8] T. Nagai,et al. Absorption of salicylic acid through the oral mucous membrane of hamster cheek pouch. , 1980, Chemical & pharmaceutical bulletin.
[9] H. Junginger,et al. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat—A comparative study with copolymers and blends based on poly(acrylic acid) , 1990 .
[10] T. Nagai,et al. Ointment-type oral mucosal dosage form of Carbopol containing prednisolone for treatment of aphtha. , 1983, Chemical & pharmaceutical bulletin.
[11] T. Save,et al. Comparative Study of Buccoadhesive Formulations and Sublingual Capsules of Nifedipine , 1994, The Journal of pharmacy and pharmacology.
[12] S. J. Sveinsson,et al. Oral mucosal adhesive ointment containing liposomal corticosteroid , 1993 .
[13] J. H. Guo,et al. Investigating the Surface Properties and Bioadhesion of Buccal Patches , 1994, The Journal of pharmacy and pharmacology.
[14] S. S. Davis,et al. The effect of polycarbophil on the gastric emptying of pellets , 1987, The Journal of pharmacy and pharmacology.
[15] Tsuneji Nagai,et al. Magnetic granules: a novel system for specific drug delivery to esophageal mucosa in oral administration , 1990 .
[16] T. Nagai,et al. Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol. , 1982, Chemical & pharmaceutical bulletin.
[17] Claus-Michael Lehr,et al. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop , 1991 .
[18] Y. Akao,et al. MUCOSA-ADHESIVE FILM CONTAINING LOCAL ANALGESIC , 1985, The Lancet.
[19] T. Nagai,et al. Topical mucosal adhesive dosage forms , 1986, Medicinal research reviews.
[20] J. Feijen,et al. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. , 1985, Biomaterials.
[21] N. Ho,et al. MECHANISTIC STUDIES IN THE SIMULTANEOUS FLOW AND ADSORPTION OF POLYMER-COATED LATEX PARTICLES ON INTESTINAL MUCUS I: METHODS AND PHYSICAL MODEL DEVELOPMENT# , 1987 .
[22] J D Smart,et al. An in‐vitro investigation of mucosa‐adhesive materials for use in controlled drug delivery , 1984, The Journal of pharmacy and pharmacology.
[23] F. Grinnell. Cellular adhesiveness and extracellular substrata. , 1978, International review of cytology.
[24] M. Taylor. The origin and functions of nasal mucus , 1974, The Laryngoscope.
[25] Nikolaos A. Peppas,et al. Pharmaceutical and Medical Aspects of Bioadhesive Systems for Drug Administration , 1988 .
[26] J. Remon,et al. In‐vitro Bioadhesion of a Buccal, Miconazole Slow‐release Tablet , 1993, The Journal of pharmacy and pharmacology.
[27] Brooks Ws. Sucralfate: nonulcer uses. American College of Gastroenterology Committee on FDA-Related Matters. , 1985 .
[28] H. Yamahara,et al. In situ perfusion system for oral mucosal absorption in dogs. , 1990, Journal of pharmaceutical sciences.
[29] A. Rakoff,et al. The Biologic Characteristics of the Normal Vagina , 1944 .
[30] F. Otero-Espinar,et al. Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly(acrylic acid) crosslinked with sucrose , 1993 .
[31] D. Coomans,et al. Development and Testing of Bioadhesive, Fluoride‐containing Slow‐release Tablets for Oral Use , 1991, The Journal of pharmacy and pharmacology.
[32] M. Rajaniemi,et al. Development of a method for study of the tendency of drug products to adhere to the esophagus. , 1982, Journal of pharmaceutical sciences.
[33] J. Smart. An m vitro assessment of some mucosa-adhesive dosage forms , 1991 .
[34] H. Strempel,et al. Novel concept for a mucosal adhesive ointment. , 1984, Journal of pharmaceutical sciences.
[35] Nagai Tsuneji,et al. Powder dosage form of insulin for nasal administration , 1984 .
[36] G. C. Hwang,et al. Adhesive and in vitro release characteristics of propranolol bioadhesive disc system , 1992 .
[37] T. Nagai,et al. Preparation and phase II clinical examination of topical dosage forms for the treatment of carcinoma colli containing bleomycin, carboquone, or 5-fluorouracil with hydroxypropyl cellulose. , 1980, Chemical and pharmaceutical bulletin.
[38] P. Turner,et al. A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the β‐blocking drugs atenolol and propranolol , 1978, The Journal of pharmacy and pharmacology.
[39] S. Mortazavi,et al. A comparative study on the role played by mucus glycoproteins in the rheological behaviour of the mucoadhesive/mucosal interface , 1993 .
[40] J. Robinson,et al. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion☆ , 1985 .
[41] S. Davis,et al. Susadrin transmucosal tablets (Nitroglycerin in Synchron® controlled-release base) , 1983 .
[42] Kinam Park,et al. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion , 1984 .
[43] T. Nagai,et al. Buccal/gingival drug delivery systems , 1987 .
[44] J. Feijen,et al. Rate-controlled rectal drug delivery in man with a hydrogel preparation , 1986 .
[45] A. Ahuja,et al. Development Of Buccal Tablets Of Diltiazem Hydrochloride , 1995 .
[46] N. Peppas,et al. Bioadhesive Tablets Influence of the Testing Medium Composition on Bioadhesion , 1989 .
[47] Nikolaos A. Peppas,et al. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues , 1985 .
[48] T. Nagai. Adhesive topical drug delivery system , 1985 .
[49] M. Al-Meshal,et al. In-Vivo Evaluation of a Bioadhesive Containing Indomethacin Tablets , 1994 .
[50] E. L. Parrott,et al. Release of highly water-soluble medicinal compounds from inert, heterogeneous matrixes. I: Physical mixture. , 1990, Journal of pharmaceutical sciences.
[51] J. Robinson,et al. Drug delivery via the mucous membranes of the oral cavity. , 1992, Journal of pharmaceutical sciences.
[52] A. D'emanuele,et al. The bioadhesive properties of a triblock copolymer of ϵ-caprolactone and ethylene oxide , 1995 .
[53] Raymond C Rowe,et al. Handbook of Pharmaceutical Excipients , 1994 .
[54] Kinam Park. A new approach to study mucoadhesion: colloidal gold staining , 1989 .
[55] S. Miller,et al. Localization of Rate-Limiting Barrier to Penetration of Endotoxin Through Nonkeratinized Oral Mucosa In Vitro , 1975, Journal of dental research.
[56] Claus-Michael Lehr,et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .
[57] S. Mortazavi,et al. Factors Influencing Gel‐strengthening at the Mucoadhesive‐mucus Interface , 1994, The Journal of pharmacy and pharmacology.
[58] J. Robinson,et al. Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. , 1985, Journal of pharmaceutical sciences.
[59] I. Kellaway,et al. IN VITRO TECHNIQUES FOR MEASURING MUCOADHESION , 1982 .
[60] P. Deasy,et al. Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride. , 1990, Journal of pharmaceutical sciences.
[61] S. H. Leung,et al. Polymer structure features contributing to mucoadhesion. II , 1990 .
[62] J. Hadgraft,et al. Absorption of drugs from the human oral cavity , 1991 .
[63] J. Robinson,et al. Bioadhesive Polymers for Controlled Drug Delivery , 1987, Annals of the New York Academy of Sciences.
[64] Vijay Kumar,et al. Chemically-Modified Celldlosic Polymers , 1993 .
[65] P. Bass,et al. Canine gastric emptying of polycarbophil: an indigestible, particulate substance. , 1985, Gastroenterology.
[66] R. Khar,et al. INTERPOLYMER COMPLEXATION AND ITS EFFECT ON BIOADHESIVE STRENGTH AND DISSOLUTION CHARACTERISTICS OF BUCCAL DRUG DELIVERY YSTEMS , 1994 .
[67] Susi Burgalassi,et al. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid , 1989 .
[68] P. Timmins,et al. Topical adhesive systems , 1990 .
[69] G. Buckton,et al. Modelling mucoadhesion by use of surface energy terms obtained by the Lewis acid-Lewis base approach , 1995 .
[70] M. Rajaniemi,et al. Effect of dosage form and formulation factors on the adherence of drugs to the esophagus. , 1983, Journal of pharmaceutical sciences.
[71] R. Good. On the Definition of Adhesion , 1976 .
[72] Jian-Hwa Guo. Bioadhesive Polymer Buccal Patches for Buprenorphine Controlled Delivery: Formulation, In-vitro Adhesion and Release Properties , 1994 .
[73] James L. Chen,et al. CHAPTER 10 – COMPOSITIONS PRODUCING ADHESION THROUGH HYDRATION , 1970 .
[74] N. Peppas,et al. Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.
[75] R. N. Brogden,et al. Sucralfate , 2012, Drugs.
[76] H. Merkle,et al. Evaluation of laminated muco-adhesive patches for buccal drug delivery , 1989 .
[77] T. Nagai,et al. Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. , 1989, Chemical & pharmaceutical bulletin.
[78] S. Mortazavi,et al. An investigation of the rheological behaviour of the mucoadhesive/mucosal interface , 1992 .
[79] Y. Chien,et al. Nasal systemic drug delivery , 1989 .
[80] N. Peppas,et al. Bioadhesive analysis of controlled-release systems. III. Bioadhesive and release behavior of metronidazole-containing poly(acrylic acid)-hydroxypropyl methylcellulose systems , 1987 .
[81] J. G. Edwards. The biochemistry of cell-adhesion , 1983 .
[82] T. Nagai,et al. Preparation and phase II clinical examination of topical dosage form for treatment of carcinoma coli containing bleomycin with hydroxypropyl cellulose. , 1979, Chemical & pharmaceutical bulletin.
[83] H Tabata,et al. Nasal absorption of nifedipine from gel preparations in rats. , 1987, Chemical & pharmaceutical bulletin.
[84] J. Smart. Some formulation factors influencing the rate of drug release from bioadhesive matrices , 1992 .
[85] T. Save,et al. Buccoadhesive Tablets of Nifedipine: Standardization of A Novel Buccoadhesive-Erodible Carrier , 1994 .
[86] L. Illum,et al. (D) Routes of delivery: Case studies , 1992 .
[87] J. Robinson,et al. Ocular delivery of progesterone using a bioadhesive polymer , 1985 .
[88] J. Robinson,et al. Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. , 1985, Journal of pharmaceutical sciences.
[89] H. Zia,et al. Mucoadhesive Drug Delivery Systems , 1993 .
[90] R. Nagashama. MECHANISM OF ACTION OF SUCRALFATE , 1981 .
[91] P. Buri,et al. A novel in situ method to test polymers and coated microparticles for bioadhesion , 1989 .
[92] Giesing Dh,et al. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. , 1981 .